Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 27, 2025Open Access

Synthetic Mimetics of Exosomal Lipid Profile Enhance Gemcitabine Delivery in Pancreatic Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

TSTina Napso ShoganZGZiv GilASAvi Schroeder

Discussion

Loading...

Member takes

Overview

Analysis shows enhanced gemcitabine delivery and tumor growth inhibition in pancreatic cancer using lipid-based drug delivery platforms.

Key Points

  • Programmed cell death significantly induced by gemcitabine-loaded synthetic exosomes compared to free drug, enhancing treatment efficacy.
  • Biodistribution studies indicate tumor specificity of synthetic exosomes, emphasizing their role in targeted cancer therapy.
  • Intracellular trafficking analysis demonstrated optimized synthetic exosome uptake in human pancreatic cancer cells, validating their design.
  • Results suggest leveraging exosomal lipid profile improves drug delivery efficiency for overcoming chemotherapy resistance.

Cite This Study

Shogan et al. (2025) studied this question.

synapsesocial.com/papers/68ff87d8c8c50a61f2bdcaf9https://doi.org/10.1101/2025.10.24.684306
View Full Paper
Ask AI
Bookmark
Share